Aviso Financial’s GSK GSK Stock Holding History

Aviso Financial’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$241K	Sell	4,604 -218	-5%	-$11.5K	0.01%	189
2026 Q1	$266K	Buy	4,822 +92	+2%	+$4.99K	0.01%	211
2025 Q4	$232K	Sell	4,730 -3,354	-41%	-$156K	0.01%	211
2025 Q3	$349K	Buy	8,084 +130	+2%	+$5.08K	0.01%	210
2025 Q2	$305K	Buy	7,954 +603	+8%	+$23K	0.01%	213
2025 Q1	$285K	Sell	7,351 -402	-5%	-$14.7K	0.01%	216
2024 Q4	$262K	Sell	7,753 -759	-9%	-$27.3K	0.01%	230
2024 Q3	$348K	Buy	8,512 +161	+2%	+$6.59K	0.02%	220
2024 Q2	$321K	Buy	+8,351	New	+$351K	0.02%	212

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Aviso Financial's GSK Position: Q2 2026 in Review

Aviso Financial reduced its GSK (GSK) stake by 4.5% in Q2 2026, selling an estimated $11.5K and leaving 4,604 shares worth $241K. The position accounts for 0.01% of the portfolio, ranked #189.

Aviso Financial first reported a position in GSK in Q2 2024 and has held it in 9 quarters since. The position peaked at $349K in Q3 2025. 1,043 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Aviso Financial held 4,604 shares of GSK worth $241K as of Q2 2026.
Aviso Financial sold 218 GSK shares in Q2 2026, an estimated $11.5K.
GSK made up 0.01% of Aviso Financial's portfolio in Q2 2026, its #189 holding.
Aviso Financial first reported a position in GSK in Q2 2024 and has held it in 9 quarters since.
Aviso Financial's GSK position peaked at $349K in Q3 2025.
1,043 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Aviso Financial's 13F filing for Q2 2026, filed 13 Aug 2026.